Lucia Nacci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lucia Nacci has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Roberto Valli
Human and Medical Genetics, Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy
4 shared publications- Antonella Minelli
Department of Molecular Medicine, University of Pavia, Pavia, Italy
3 shared publications Cesare Danesino
Department of Molecular Medicine, University of Pavia, Pavia, Italy
3 shared publicationsFrancesco Pasquali
Human and Medical Genetics, Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy
3 shared publications- Jacopo Morini
Department of Physics, University of Pavia, Pavia, Italy
3 shared publications Marco Cipolli
Cystic Fibrosis Centre, Azienda Ospedaliera Universitaria, Verona, Italy
3 shared publications
Latest Publications
- 3 February 2026
- Published by Springer Nature
- Vol. 3015, 55-71
High-Resolution Laser Microdissection to Investigate Transcriptional States in Formalin-Fixed Paraffin-Embedded Samples
The advent of spatially resolved transcriptomics has revolutionized our understanding of tissue heterogeneity. While advanced spatial transcriptomics (ST) technologies offer unparalleled and unbiased, whole-slide molecular mapping, laser microdissection (LMD) remains a highly valuable and often superior approach for specific research questions, particularly when coupled with RNA sequencing (RNA-seq). LMD provides high spatial resolution through precise morphological annotation, allowing for the isolation of defined cell clusters or even rare populations from complex tissues. This enables deeper and more sensitive transcriptomic profiling than is often achievable with some high-throughput ST methods that depend on computational deconvolution. Crucially, LMD is well established for use with routine histological samples, including challenging formalin-fixed paraffin-embedded (FFPE) specimens, facilitating invaluable retrospective studies on large patient cohorts. Unlike emerging ST platforms that can present significant per-sample costs and substantial computational overhead, targeted LMD-RNA-seq offers a more cost-effective and scalable solution for analyzing numerous specific regions across large numbers of patients. Therefore, a robust protocol outlining the use of LMD for routine histological samples, coupled with RNA-seq, remains an invaluable tool for discovery, enabling highly specific molecular insights from clinically relevant biospecimens.
- 3 February 2026
- Published by Springer Nature
- Vol. 3015, 55-71
High-Resolution Laser Microdissection to Investigate Transcriptional States in Formalin-Fixed Paraffin-Embedded Samples
The advent of spatially resolved transcriptomics has revolutionized our understanding of tissue heterogeneity. While advanced spatial transcriptomics (ST) technologies offer unparalleled and unbiased, whole-slide molecular mapping, laser microdissection (LMD) remains a highly valuable and often superior approach for specific research questions, particularly when coupled with RNA sequencing (RNA-seq). LMD provides high spatial resolution through precise morphological annotation, allowing for the isolation of defined cell clusters or even rare populations from complex tissues. This enables deeper and more sensitive transcriptomic profiling than is often achievable with some high-throughput ST methods that depend on computational deconvolution. Crucially, LMD is well established for use with routine histological samples, including challenging formalin-fixed paraffin-embedded (FFPE) specimens, facilitating invaluable retrospective studies on large patient cohorts. Unlike emerging ST platforms that can present significant per-sample costs and substantial computational overhead, targeted LMD-RNA-seq offers a more cost-effective and scalable solution for analyzing numerous specific regions across large numbers of patients. Therefore, a robust protocol outlining the use of LMD for routine histological samples, coupled with RNA-seq, remains an invaluable tool for discovery, enabling highly specific molecular insights from clinically relevant biospecimens.
- Open Access
- 7 September 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 15 (37) , 15382-15395
Native extracellular matrix probes to target patient- and tissue-specific cell–microenvironment interactions by force spectroscopy
Native extracellular matrix probes for Atomic Force Microscopy can be successfully used for the quantitative investigation of the cellular mechanosensing of the microenvironment.
- 7 September 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 15 (37) , 15382-15395
Open AccessNative extracellular matrix probes to target patient- and tissue-specific cell–microenvironment interactions by force spectroscopy
Native extracellular matrix probes for Atomic Force Microscopy can be successfully used for the quantitative investigation of the cellular mechanosensing of the microenvironment.
- 21 December 2018
- Published by Wiley in British Journal of Haematology
- Vol. 184 (5) , 710-711
Genetics for understanding the clinical features of Shwachman‐Diamond Syndrome
- 21 December 2018
- Published by Wiley in British Journal of Haematology
- Vol. 184 (5) , 710-711
Genetics for understanding the clinical features of Shwachman‐Diamond Syndrome
- Open Access
- 10 September 2018
- Published by Wiley in British Journal of Haematology
- Vol. 185 (3) , 627-630
Whole exome sequencing discloses heterozygous variants in the DNAJC21 and EFL1 genes but not in SRP54 in 6 out of 16 patients with Shwachman‐Diamond Syndrome carrying biallelic SBDS mutations
- 10 September 2018
- Published by Wiley in British Journal of Haematology
- Vol. 185 (3) , 627-630
Open AccessWhole exome sequencing discloses heterozygous variants in the DNAJC21 and EFL1 genes but not in SRP54 in 6 out of 16 patients with Shwachman‐Diamond Syndrome carrying biallelic SBDS mutations
- 28 January 2017
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 64 (8)
Novel recurrent chromosome anomalies in Shwachman–Diamond syndrome
Background: Two chromosome anomalies are frequent in the bone marrow (BM) of patients with Shwachman–Diamond syndrome (SDS): an isochromosome of the long arm of chromosome 7, i(7)(q10), and an interstitial deletion of the long arm of chromosome 20, del(20)(q). These anomalies are associated with a lower risk of developing myelodysplasia (MDS) and/or acute myeloid leukemia. The chromosome anomalies may be due to an SDS‐specific karyotype instability, reflected also by anomalies that are not clonal, but found in single cells in the BM or in peripheral blood (PB).Procedure: Starting in 1999, we have monitored the cytogenetic picture of a cohort of 91 Italian patients with SDS by all suitable cytogenetic and molecular methods.Results: Here, we report clonal chromosome anomalies that are different from the aforementioned, as well as changes found in single cells in BM/PB of the same patients.Conclusions: Some of the newly recognized clonal anomalies in BM reported here are recurrent, especially unbalanced structural anomalies of chromosome 7, a further complex rearrangement of the del(20)(q) with duplicated and deleted portions, and an unbalanced translocation t(3;6), with partial trisomy of the long arm of chromosome 3 and partial monosomy of the long arm of chromosome 6. Firm conclusions on the possible prognostic relevance of these anomalies would require further study with larger patient cohorts, but our data are sufficient to suggest that these patients necessitate more frequent cytogenetic monitoring. The results on anomalies found in single cells confirm the presence of an SDS‐specific karyotype instability.
- 28 January 2017
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 64 (8)
Novel recurrent chromosome anomalies in Shwachman–Diamond syndrome
Background: Two chromosome anomalies are frequent in the bone marrow (BM) of patients with Shwachman–Diamond syndrome (SDS): an isochromosome of the long arm of chromosome 7, i(7)(q10), and an interstitial deletion of the long arm of chromosome 20, del(20)(q). These anomalies are associated with a lower risk of developing myelodysplasia (MDS) and/or acute myeloid leukemia. The chromosome anomalies may be due to an SDS‐specific karyotype instability, reflected also by anomalies that are not clonal, but found in single cells in the BM or in peripheral blood (PB).Procedure: Starting in 1999, we have monitored the cytogenetic picture of a cohort of 91 Italian patients with SDS by all suitable cytogenetic and molecular methods.Results: Here, we report clonal chromosome anomalies that are different from the aforementioned, as well as changes found in single cells in BM/PB of the same patients.Conclusions: Some of the newly recognized clonal anomalies in BM reported here are recurrent, especially unbalanced structural anomalies of chromosome 7, a further complex rearrangement of the del(20)(q) with duplicated and deleted portions, and an unbalanced translocation t(3;6), with partial trisomy of the long arm of chromosome 3 and partial monosomy of the long arm of chromosome 6. Firm conclusions on the possible prognostic relevance of these anomalies would require further study with larger patient cohorts, but our data are sufficient to suggest that these patients necessitate more frequent cytogenetic monitoring. The results on anomalies found in single cells confirm the presence of an SDS‐specific karyotype instability.
- 21 September 2016
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 56 (1) , 51-58
Parental origin of the deletion del(20q) in Shwachman-Diamond patients and loss of the paternally derived allele of the imprintedL3MBTL1gene
Shwachman–Diamond syndrome (SDS) (OMIM 260400) is a rare autosomal recessive disease characterized by exocrine pancreatic insufficiency, skeletal, and hematological abnormalities and bone marrow (BM) dysfunction. Mutations in the SBDS gene cause SDS. Clonal chromosome anomalies are often present in BM, i(7)(q10) and del(20q) being the most frequent ones. We collected 6 SDS cases with del(20q): a cluster of imprinted genes, including L3MBTL1 and SGK2 is present in the deleted region. Only the paternal allele is expressed for these genes. Based on these data, we made the hypothesis that the loss of this region, in relation to parental origin of deletion, may be of relevance for the hematological phenotype. By comparing hematological data of our 6 cases with a group of 20 SDS patients without evidence of del(20q) in BM, we observed a significant difference for Hb levels (P < 0.012), and a difference slightly above the significance level for RBC counts (P < 0.053): in both cases the values were higher in patients with del(20q). We also report preliminary evidence for an increased number of BFU-E colonies in cases with paternal deletion, data on the presence of the deletion in colonies and in mature circulating lymphocytes.
- 21 September 2016
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 56 (1) , 51-58
Parental origin of the deletion del(20q) in Shwachman-Diamond patients and loss of the paternally derived allele of the imprintedL3MBTL1gene
Shwachman–Diamond syndrome (SDS) (OMIM 260400) is a rare autosomal recessive disease characterized by exocrine pancreatic insufficiency, skeletal, and hematological abnormalities and bone marrow (BM) dysfunction. Mutations in the SBDS gene cause SDS. Clonal chromosome anomalies are often present in BM, i(7)(q10) and del(20q) being the most frequent ones. We collected 6 SDS cases with del(20q): a cluster of imprinted genes, including L3MBTL1 and SGK2 is present in the deleted region. Only the paternal allele is expressed for these genes. Based on these data, we made the hypothesis that the loss of this region, in relation to parental origin of deletion, may be of relevance for the hematological phenotype. By comparing hematological data of our 6 cases with a group of 20 SDS patients without evidence of del(20q) in BM, we observed a significant difference for Hb levels (P < 0.012), and a difference slightly above the significance level for RBC counts (P < 0.053): in both cases the values were higher in patients with del(20q). We also report preliminary evidence for an increased number of BFU-E colonies in cases with paternal deletion, data on the presence of the deletion in colonies and in mature circulating lymphocytes.
- 1 September 2016
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 60, 33-35
Structural variation in SBDS gene, with loss of exon 3, in two Shwachman-Diamond patients
- 1 September 2016
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 60, 33-35
Structural variation in SBDS gene, with loss of exon 3, in two Shwachman-Diamond patients
- 12 April 2015
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 166 (1-4) , 95-100
Radiosensitivity in lymphoblastoid cell lines derived from Shwachman–Diamond syndrome patients
Shwachman–Diamond syndrome is an autosomal-recessive disorder characterised by bone marrow failure and a cumulative risk of progression to acute myeloid leukaemia. The Shwachman–Bodian–Diamond syndrome (SBDS) gene, the only gene known to be causative of the pathology, is involved in ribosomal biogenesis, stress responses and DNA repair, and the lack of SBDS sensitises cells to many stressors and leads to mitotic spindle destabilisation. The effect of ionising radiation on SBDS-deficient cells was investigated using immortalised lymphocytes from SDS patients in comparison with positive and negative controls in order to test whether, in response to ionising radiation exposure, any impairment in the DNA repair machinery could be observed. After irradiating cells with different doses of X-rays or gamma-rays, DNA repair kinetics and the residual damages using the alkaline COMET assay and the γ-H2AX assay were assessed, respectively. In this work, preliminary data about the comparison between ionising radiation effects in different patients-derived cells and healthy control cells are presented.
- 12 April 2015
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 166 (1-4) , 95-100
Radiosensitivity in lymphoblastoid cell lines derived from Shwachman–Diamond syndrome patients
Shwachman–Diamond syndrome is an autosomal-recessive disorder characterised by bone marrow failure and a cumulative risk of progression to acute myeloid leukaemia. The Shwachman–Bodian–Diamond syndrome (SBDS) gene, the only gene known to be causative of the pathology, is involved in ribosomal biogenesis, stress responses and DNA repair, and the lack of SBDS sensitises cells to many stressors and leads to mitotic spindle destabilisation. The effect of ionising radiation on SBDS-deficient cells was investigated using immortalised lymphocytes from SDS patients in comparison with positive and negative controls in order to test whether, in response to ionising radiation exposure, any impairment in the DNA repair machinery could be observed. After irradiating cells with different doses of X-rays or gamma-rays, DNA repair kinetics and the residual damages using the alkaline COMET assay and the γ-H2AX assay were assessed, respectively. In this work, preliminary data about the comparison between ionising radiation effects in different patients-derived cells and healthy control cells are presented.
- Open Access
- 1 February 2014
- Published by Wiley in British Journal of Haematology
- Vol. 165 (4) , 573-575
Absence of acquired copy number neutral loss of heterozygosity (CN-LOH) of chromosome 7 in a series of 10 patients with Shwachman-Diamond syndrome
- 1 February 2014
- Published by Wiley in British Journal of Haematology
- Vol. 165 (4) , 573-575
Open AccessAbsence of acquired copy number neutral loss of heterozygosity (CN-LOH) of chromosome 7 in a series of 10 patients with Shwachman-Diamond syndrome